Continuous glucose monitoring in metabolic surgery
Part of Hormones & metabolism clinical trials.
This study uses continuous glucose monitors (CGMs), small devices that track blood sugar levels, in people having weight-loss (metabolic) surgery. It aims to understand how blood sugar changes after surgery and may help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 60 years old
- Your body mass index (BMI) is 35 or higher
- You do not have type 1 diabetes
- You are not pregnant or breastfeeding
- You are not currently on insulin therapy
- You are not having revisional surgery (a repeat weight-loss surgery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether wearing a continuous glucose monitor (a small sensor on your skin that tracks your blood sugar) can help people with prediabetes and obesity better control their blood sugar and lose weight. You will be asked to wear the device for several days to see how your glucose levels change throughout the day.
This study tests if using a continuous glucose monitor (CGM), a small device that tracks blood sugar, can help children and teens with obesity understand their body better and improve their health.
This trial tests how well continuous glucose monitors (CGMs) work during surgery and hospital stays in young people with type 1 diabetes. It aims to make sure these devices give accurate readings when they are most needed.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar in people with diabetes and gastroparesis (slow stomach emptying). If you have type 1 or type 2 diabetes and stomach symptoms, this could help doctors better understand your glucose patterns.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.